Early Individualized Psychosocial Assets to Facilitate the Return to Employment of Women With Breast Cancer
18 Years
55 Years
Female
Breast Cancer
Trial Information
Early Individualized Psychosocial Assets to Facilitate the Return to Employment of Women With Breast Cancer
For the group "intervention", patients have four interviews with a psychologist (at cure one
of chemotherapy treatment, at cure six of chemotherapy treatment, at last radiotherapy
session, and three months after the end of radiotherapy).
In the 2 arms, patients receive 4 sets of questionnaires (baseline, month 12, month 18 and
month 24)
Inclusion Criteria:
- Women ≥ 18 to ≤ 55 years
- Presenting a unilateral breast cancer exclusively local extension
- Having received surgery
- Reporting of adjuvant chemotherapy (+ / - trastuzumab)
- Reporting to radiotherapy or not (If radiotherapy, it will be done on site
investigator)
- In work at the time of diagnosis (employees, traders and professionals)
- Patient affiliated to a social security scheme
- Consent signed by the patient before the implementation of any specific procedure to
study
Exclusion Criteria:
- Presence of in situ lesions, cancer recurrence, metastatic disease immediately,
location bilateral
- Inability physical, psychological, psychiatric or cognitive responses to the
questionnaires and participate in interviews
- Recognition previous ALD (due to another disease)
- Patient under guardianship
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Comparison of the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work
Outcome Time Frame:
At 24 months
Safety Issue:
No
Authority:
France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study ID:
APAPI-1202
NCT ID:
NCT01780064
Start Date:
February 2013
Completion Date:
September 2016
Related Keywords:
- Breast Cancer
- Breast Neoplasms
Name | Location |
|---|
